You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SGRQ

Showing 1 - 25 of 886
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Turkish Validity and Reliability of SGRQ-I

Recruiting
  • IPF
  • Questionnaire
  • İstanbul, Üsküdar, Turkey
    Esra Pehlivan
Jan 9, 2022

Patient Adherence Trial in Cali (Education plan and adherence to exercise)

Completed
  • Patient Adherence
  • Education plan and adherence to exercise
  • Cali, Valle, Colombia
    Juan Carlos Avila
Jan 19, 2022

COVID-19 Related Lung Ventilation and Perfusion Injury

Recruiting
  • Covid-19
  • +2 more
  • V/Q SPECT-CT
  • +6 more
  • Hamilton, Ontario, Canada
    St. Joseph's Healthcare Hamilton
Sep 9, 2021

Best Clinical Endpoints That Likely Induce Worse Prognosis in

Recruiting
  • Interstitial Lung Disease
  • Daily physical activity levels
  • +14 more
  • Londrina, Paraná, Brazil
    Universidade Estadual de Londrina
Jul 26, 2021

Breathing Exercises Trial in Erzurum (Breathing exercises)

Completed
  • Breathing Exercises
  • Breathing exercises
  • Erzurum, Turkey
    Atatürk University Faculty of Nursing
Jan 6, 2023

Pulmonary Disease, Chronic Obstructive, Health-Related Quality Of Life, Dyspnea Trial in Ordu, Malatya (Exercise)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • +2 more
  • Exercise
  • Ordu, Altınordu, Turkey
  • +1 more
May 26, 2023

Functional Imaging in Lung SBRT

Completed
  • Lung Cancer
  • CT Scan
  • +7 more
  • Ann Arbor, Michigan
    University of Michigan
Oct 16, 2019

Quality of Life in Male and Female Adult Severe Asthma Treated

Not yet recruiting
  • Asthma
    • (no location specified)
    Aug 31, 2023

    COPD (COPD) Trial in Worldwide (Placebo, Tozorakimab)

    Not yet recruiting
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Sheffield, Alabama
    • +31 more
    Sep 11, 2023

    Non-cystic Fibrosis Bronchiectasis Trial in United States (ARINA-1, Placebo)

    Not yet recruiting
    • Non-cystic Fibrosis Bronchiectasis
    • Birmingham, Alabama
    • +8 more
    Aug 10, 2022

    Pulmonary Disease, Chronic Obstructive Trial in Beijing, Shenzhen, Shanghai (611 300 mg Q2W, 611 450 mg Q2W, Matching )

    Not yet recruiting
    • Pulmonary Disease, Chronic Obstructive
    • 611 300 mg Q2W
    • +2 more
    • Beijing, Beijing, China
    • +2 more
    Oct 25, 2023

    Symptom and Quality of Life in COPD by

    Recruiting
    • Pulmonary Disease, Chronic Obstructive
      • Nagoya, Aichi, Japan
      • +16 more
      Jan 17, 2023

      Real-world, 52-week Prospective Study to Capture Reasons for

      Not yet recruiting
      • Pulmonary Disease, Chronic Obstructive (COPD)
      • Budesonide Glycopyrronium bromide Formoterol fumarate pressurized Metered Dose Inhaler
      • (no location specified)
      Jun 13, 2023

      COPD, Lung Diseases, Obstructive Trial in Shanghai (TCM Daoyin, Health education)

      Recruiting
      • Chronic Obstructive Pulmonary Disease
      • Lung Diseases, Obstructive
      • TCM Daoyin
      • Health education
      • Shanghai, Shanghai, China
      • +1 more
      Jul 4, 2023

      Emphysema or COPD Trial in St. Polten, Groningen, London (Apreo Implant Group)

      Not yet recruiting
      • Emphysema or COPD
      • Apreo Implant Group
      • St. Polten, Austria
      • +2 more
      Jul 10, 2023

      Emphysema or COPD Trial in Macquarie, Parkville (Apreo Implant Group)

      Not yet recruiting
      • Emphysema or COPD
      • Apreo Implant Group
      • Macquarie, New South Wales, Australia
      • +1 more
      May 2, 2023

      Idiopathic Pulmonary Fibrosis Trial (TDI01 suspension)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • TDI01 suspension
      • (no location specified)
      Oct 30, 2023

      Chronic Respiratory Disease Trial in Hauteville-Lompnes (Adapted information arm, Neutral information arm)

      Recruiting
      • Chronic Respiratory Disease
      • Adapted information arm
      • Neutral information arm
      • Hauteville-Lompnes, France
      • +1 more
      Jan 16, 2023

      COPD Trial in Guangzhou (Ensifentrine, Placebo)

      Not yet recruiting
      • Chronic Obstructive Pulmonary Disease
      • Guangzhou, Guangdong, China
        1st Affiliated Hospital of Guangzhou Medical University
      Feb 28, 2023

      Severe Emphysema Trial (BTVA treatment plus optimal medical therapy (GOLD guidelines))

      Not yet recruiting
      • Severe Emphysema
      • BTVA treatment plus optimal medical therapy (GOLD guidelines)
      • (no location specified)
      Nov 21, 2023

      COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)

      Active, not recruiting
      • Chronic Obstructive Pulmonary Disease
      • Dupilumab SAR231893
      • +4 more
      • Andalusia, Alabama
      • +286 more
      May 11, 2022

      COPD, OSA, Lung Function Decreased Trial in Ratchathewi (CPAP therapy, Control)

      Not yet recruiting
      • COPD
      • +2 more
      • CPAP therapy
      • Control
      • Ratchathewi, Bangkok, Thailand
        Faculty of Medicine Ramathibodi Hospital, Mahidol University
      May 4, 2023

      COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)

      Recruiting
      • Chronic Obstructive Pulmonary Disease
      • Itepekimab SAR440340
      • Placebo
      • Birmingham, Alabama
      • +158 more
      Jul 13, 2022

      Idiopathic Pulmonary Fibrosis Trial in Rome (Autologous FMT, Placebo FMT)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Autologous FMT
      • Placebo FMT
      • Rome, Roma, Italy
        Fondazione Policlinico Agostino Gemelli IRCCS
      Feb 23, 2023

      COPD Trial in Chengdu (TLD, Sham TLD procedure, Standard of care)

      Not yet recruiting
      • COPD
      • TLD
      • +2 more
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      Apr 3, 2023